Campus Career 【 display / non-display 】
-
2024.11-NowInstitute of Science Tokyo, -, Graduate Schools, Biomedical Laboratory Sciences, Department of Pathology and Anatomical Sciences, Assistant Professor
Research Theme 【 display / non-display 】
Published Papers & Misc 【 display / non-display 】
-
Erina Iwabuchi, Yasuhiro Miki, Junyao Xu, Ayako Kanai, Takanori Ishida, Takashi Suzuki. Tetraspanins CD63 and CD81 as potential prognostic biomarkers in breast cancer. Breast cancer. 2025.01; 32 (2): 393-403. ( PubMed, DOI )
-
Erina Iwabuchi, Yasuhiro Miki, Junyao Xu, Ayako Kanai, Takanori Ishida, Hironobu Sasano, Takashi Suzuki. Zinc transporter ZnT5 is associated with epithelial mesenchymal transition via SMAD1 in breast cancer. International journal of experimental pathology. 2024.10; 105 (5): 184-192. ( PubMed, DOI )
-
Nattamolphan Wittayavimol, Erina Iwabuchi, Prangwan Pateetin, Yasuhiro Miki, Yoshiaki Onodera, Hironobu Sasano, Viroj Boonyaratanakornkit. Progesterone receptor-Grb2 interaction is associated with better outcomes in breast cancer. The Journal of steroid biochemistry and molecular biology. 2024.03; 237 106441. ( PubMed, DOI )
-
Yasuhiro Miki, Erina Iwabuchi, Kiyoshi Takagi, Yuto Yamazaki, Yusuke Shibuya, Hideki Tokunaga, Muneaki Shimada, Takashi Suzuki, Kiyoshi Ito. Intratumoral cortisol associated with aromatase in the endometrial cancer microenvironment. Pathology, research and practice. 2023.11; 251 154873. ( PubMed, DOI )
-
Satoko Tsunokake, Erina Iwabuchi, Yasuhiro Miki, Ayako Kanai, Yoshiaki Onodera, Hironobu Sasano, Takanori Ishida, Takashi Suzuki. SGLT1 as an adverse prognostic factor in invasive ductal carcinoma of the breast. Breast cancer research and treatment. 2023.10; 201 (3): 499-513. ( PubMed, DOI )
-
Junjia Zhang, Yasuhiro Miki, Erina Iwabuchi, Junyao Xu, Ayako Kanai, Yasuaki Sagara, Yasuyo Ohi, Yoshiaki Rai, Rin Yamaguchi, Maki Tanaka, Takanori Ishida, Takashi Suzuki, Hironobu Sasano. Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients. Breast cancer research and treatment. 2023.08; 200 (3): 323-335. ( PubMed, DOI )
-
Akiko Ebata, Takashi Suzuki, Narumi Shoji-Harada, Yohei Hamanaka, Minoru Miyashita, Erina Iwabuchi, Kiyoshi Takagi, Yasuhiro Miki, Hiroshi Tada, Takanori Ishida. Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic Predictor. Acta histochemica et cytochemica. 2023.08; 56 (4): 59-66. ( PubMed, DOI )
-
Mio Yamaguchi-Tanaka, Kiyoshi Takagi, Yasuhiro Miki, Ai Sato, Erina Iwabuchi, Minoru Miyashita, Takashi Suzuki. The Pro-Tumorigenic Role of Chemotherapy-Induced Extracellular HSP70 from Breast Cancer Cells via Intratumoral Macrophages. Cancers. 2023.03; 15 (6): 1903. ( PubMed, DOI )
-
Yasuhiro Miki, Erina Iwabuchi, Takashi Suzuki. In Situ Proximity Ligation Assay to Visualize Protein-Protein Interactions in Tumor Specimens. Methods in molecular biology. 2023; 2660 123-135. ( PubMed, DOI )
-
Erina Iwabuchi, Yasuhiro Miki, Takashi Suzuki, Hironobu Sasano. Visualization of the protein-protein interactions of hormone receptors in hormone-dependent cancer research. Endocrine Oncology. 2022.10; 2 (1): R132-R142. ( PubMed, DOI )
-
Junyao Xu, Erina Iwabuchi, Yasuhiro Miki, Ayako Kanai, Kiyoshi Takagi, Takashi Suzuki, Takanori Ishida, Hironobu Sasano. FE65 defines the efficacy of tamoxifen treatment via osteopontin expression in estrogen receptor-positive breast cancer. Pathology, research and practice. 2022.06; 234 153898. ( PubMed, DOI )
-
Yasuhiro Miki, Erina Iwabuchi, Kiyoshi Takagi, Takashi Suzuki, Hironobu Sasano, Nobuo Yaegashi, Kiyoshi Ito. Co-expression of nuclear heterogeneous nuclear ribonucleic protein K and estrogen receptor α in endometrial cancer Pathology - Research and Practice. 2022.03; 231 153795. ( DOI )
-
Junyao Xu, Erina Iwabuchi, Yasuhiro Miki, Ayako Kanai, Takanori Ishida, Hironobu Sasano. FE65 in breast cancer and its clinicopathological significance. Breast cancer. 2022.01; 29 (1): 144-155. ( PubMed, DOI )
-
Naoko Hashimoto Takigami, Shimpei Kuniyoshi, Yasuhiro Miki, Kentaro Tamaki, Yoshihiko Kamada, Kano Uehara, Seiko Tsuchiya, Shigeharu Terukina, Erina Iwabuchi, Ayako Kanai, Minoru Miyashita, Takanori Ishida, Nobumitsu Tamaki, Hironobu Sasano. Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations. Breast cancer research and treatment. 2022.01; 191 (1): 221. ( PubMed, DOI )
-
The Visualization of Protein-Protein Interactions in Breast Cancer: Deployment Study in Pathological Examination. 2021.12; 54 (6): 177-183. ( PubMed, DOI )
-
Breast Cancer, Diabetes Mellitus and Glucagon-Like Peptide-1 Receptor Toward Exploring Their Possible Associations. 2021.08; 189 (1): 39-48. ( PubMed, DOI )
-
Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling. 2020.02; 180 (1): 97-110. ( PubMed, DOI )
-
Kuniyoshi S, Miki Y, Sasaki A, Iwabuchi E, Ono K, Onodera Y, Hirakawa H, Ishida T, Yoshimi N, Sasano H. The significance of lipid accumulation in breast carcinoma cells through perilipin 2 and its clinicopathological significance. Pathology international. 2019.07; 69 (8): 463-471. ( PubMed, DOI )
-
Iwabuchi E, Miki Y, Onodera Y, Shibahara Y, Takagi K, Suzuki T, Ishida T, Sasano H. Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells. Clinical & experimental metastasis. 2019.06; 36 (5): 423-432. ( PubMed, DOI )
Conference Activities & Talks 【 display / non-display 】
-
岩渕英里奈, 三木康宏, 石井博子, 山崎あすみ,石田孝宣,鈴木貴. HER2結合タンパクによるHER2低発現乳癌の特徴の解明. 第65回日本組織細胞化学会総会・学術集会 2024.10.26
-
Yasuhiro Miki, Erina Iwabuchi, Hiroko Ishii, Kiyohsi Takagi, Muneaki Shimada, Kiyoshi Ito, Takashi Suzuki. Lipid metabolism in endometrial cancer: significance of carnitine palmitoyltransferase 2 in cancer malignant behavior. 第83回 日本癌学会学術総会 2024.09.21
-
Erina Iwabuchi, Yasuhiro Miki, Takanori Ishida, Takashi Suzuki. The clinicopathological significance of zinc transporters in breast cancer. 第83回 日本癌学会学術総会 2024.09.19
-
Ryoki Nishiwaki, Yasuhiro Miki, Erina Iwabuchi, Asumi Yamazaki, Akiko Ebata, Takanori Ishida, Takashi Suzuki. Intratumoral cortisol and 11β-hydroxysteroid dehydrogenase 1 expression in estrogen receptor-negative breast cancer. 第83回 日本癌学会学術総会 2024.09.19
-
角掛 聡子, 岩渕 英里奈, 三木 康宏, 金井 綾子, 小野寺 好明, 石田 孝宣, 笹野 公伸, 鈴木 貴. Expression of SGLT1 and SGLT2 in Breast Cancer and Potential Anticancer Effects of SGLT1 Inhibitors. 第82回 日本癌学会学術総会 2023.09.23
-
山口 美桜, 高木 清司, 三木 康宏, 岩渕 英里奈, 宮下 穣, 鈴木 貴. 化学療法誘導性細胞外HSP70はマクロファージの腫瘍促進作用を介して乳癌の進展を促進する(Chemotherapy-induced extracellular HSP70 enhances the ability of marcophages to promote breast cancer progression.). 日本癌学会総会記事 2022.09.01
-
Erina Iwabuchi, Kento Iida, Yasuhiro Miki, Koki Hasegawa, Takumi Fukasawa, Takanori Ishida, Hironobu Sasano, Takashi Suzuki. Detection of somatostatin receptors using ligand derivative staining in breast cancer. 第81回 日本癌学会学術総会 2022.09.01
-
Takumi Fukasawa, Erina Iwabuchi, Yasuhiro Miki, Koki Hasegawa, Yoshiaki Onodera, Takanori Ishida, Hironobu Sasano, Takashi Suzuki. Effects of G protein-coupled estrogen receptor and estrogen receptor β on triple-negative breast cancer. 第81回 日本癌学会学術総会 2022.09.01
-
Erina Iwabuchi, Yasuhiro Miki, Junyao Xu, Takanori Ishida, Hironobu Sasano. Zinc transporter ZnT5 Involvement in Epithelial Mesenchymal Transition in Breast Cancer. ENDO2022 2022.06.11
-
Mio Yamaguchi, Kiyoshi Takagi, Yasuhiro Miki, Erina Iwabuchi, Minoru Miyashita, Hironobu Sasano, Takashi Suzuki. Chemotherapy-induced extracellular HSP70 enhances pro-tumorigenic effects of macrophages in breast cancers. ENDO2022 2022.06.11
-
Yasuhiro Miki, Hiyori Naraoka, Erina Iwabuchi, Ai Sato, Kiyoshi Takagi, Hironobu Sasano, Takanori Ishida, Takashi Suzuki, Kiyoshi Ito. Fatty acid metabolism-related factors in breast and endometrial cancers. ENDO2022 2022.06.11
-
張 峻嘉, 岩渕 英里奈, 徐 君瑶, 三木 康宏, 金井 綾子, 石田 孝宣, 笹野 公伸. TNBCにおけるSGK1の侵襲性生物学役割. 日本癌学会総会記事 2021.09.01
-
深澤 匠, 岩渕 英里奈, 三木 康宏, 長谷川 功紀, 小野寺 好明, 石田 孝宣, 笹野 公伸. リガンド誘導体染色を用いたG-Protein Estrogen Reeptorの発現意義の解析. 日本癌学会総会記事 2021.09.01
-
岩渕 英里奈, 三木 康宏, 金井 綾子, 石田 孝宣, 笹野 公伸. 乳癌におけるCaveolin-1とエクソソームの関係. 日本癌学会総会記事 2021.09.01
-
山口 美桜, 高木 清司, 三木 康宏, 岩渕 英里奈, 宮下 穣, 笹野 公伸, 鈴木 貴. 乳癌細胞における化学療法誘導性エクソソーム内包HSP70はマクロファージの腫瘍促進作用を誘導する. 日本癌学会総会記事 2021.09.01
-
三木 康宏, 岩渕 英里奈, 高木 清司, 鈴木 貴, 笹野 公伸, 伊藤 潔. 子宮内膜癌におけるhnRNPKとエストロゲン受容体αの発現. 日本癌学会総会記事 2021.09.01
-
張 峻嘉, 三木 康宏, Junjia Zhang, Xu Junyao, Iwabuchi Erina, Miki Yasuhiro, Kanai Ayako, Ishida Takanori, Sasano Hironobu. TNBCのmalignant behaviorへのSGK1の関与(SGK1 is involved in malignant behavior of TNBC.). 日本乳癌学会総会プログラム抄録集 2021.07.01
-
徐 君瑶, 岩渕 英里奈, 三木 康宏, 石田 孝宣, 笹野 公伸. 乳癌細胞におけるFe65発現の生物学/臨床的意義の検索. 日本癌学会総会記事 2020.10.01
-
國吉 慎平, 三木 康宏, 岩渕 英里奈, 小野寺 好明, 石田 孝宣, 吉見 直己, 笹野 公伸. 乳癌細胞におけるperilipin 2と脂肪滴の意義(The significance of lipid accumulation in breast carcinoma cells through perilipin 2). 日本癌学会総会記事 2019.09.01
-
岩渕 英里奈, 三木 康宏, 石田 孝宣, 笹野 公伸. 乳癌におけるheterogeneous nuclear ribonucleoprotein Kの発現意義の検討(The expression of heterogeneous nuclear ribonucleoprotein K in breast cancer). 日本癌学会総会記事 2019.09.01
-
Iwabuchi Erina, Miki Yasuhiro, Sasano Hironobu. 乳癌細胞のestrogen受容体ダイマーの可視化(Visualization of estrogen receptor dimers in breast cancer cells). 日本内分泌学会雑誌 2019.04.01
-
Wittayavimol Nattamolphan, Iwabuchi Erina, Miki Yasuhiro, Onodera Yoshiaki, Pateetin Prangwan, Sasano Hironobu, Boonyaratanakornkit Viroj. 乳癌細胞におけるGrb2とprogesterone受容体との相互作用による核外シグナル伝達(Grb2 and Progesterone Receptor Interaction Mediated Extranuclear Signaling in Breast Cancer Cells). 日本内分泌学会雑誌 2019.04.01
-
岩渕 英里奈, 三木 康宏, 櫻井 美奈子, 宮下 穣, 金井 綾子, 石田 孝宣, 笹野 公伸. トラスツズマブ奏功性におけるHER2と癌胎児性抗原関連細胞接着分子6の相互作用の意義の検討. 日本癌学会総会記事 2017.09.01
-
菊地 杏子, McNamara Keely M., 三木 康宏, 岩渕 英里奈, 宮下 穣, 石田 孝宣, 大内 憲明, 笹野 公伸. S100Pとezrinはトリプルネガティブ乳癌の経内皮浸潤を促進する. 日本癌学会総会記事 2017.09.01